- Home
- GROY vs MRVI Comparison
GROY vs MRVI Comparison
Compare GROY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- MRVI
- Stock Information
- Founded
- GROY 2020
- MRVI 2014
- Country
- GROY Canada
- MRVI United States
- Employees
- GROY N/A
- MRVI N/A
- Industry
- GROY
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- MRVI Health Care
- Exchange
- GROY Nasdaq
- MRVI Nasdaq
- Market Cap
- GROY 322.2M
- MRVI 371.8M
- IPO Year
- GROY 2021
- MRVI 2020
- Fundamental
- Price
- GROY $3.62
- MRVI $2.42
- Analyst Decision
- GROY Strong Buy
- MRVI Hold
- Analyst Count
- GROY 4
- MRVI 10
- Target Price
- GROY $4.58
- MRVI $5.84
- AVG Volume (30 Days)
- GROY 2.5M
- MRVI 1.5M
- Earning Date
- GROY 08-06-2025
- MRVI 08-11-2025
- Dividend Yield
- GROY N/A
- MRVI N/A
- EPS Growth
- GROY N/A
- MRVI N/A
- EPS
- GROY N/A
- MRVI N/A
- Revenue
- GROY $12,376,000.00
- MRVI $219,830,000.00
- Revenue This Year
- GROY $82.74
- MRVI N/A
- Revenue Next Year
- GROY $51.73
- MRVI $7.23
- P/E Ratio
- GROY N/A
- MRVI N/A
- Revenue Growth
- GROY 90.37
- MRVI N/A
- 52 Week Low
- GROY $1.16
- MRVI $1.67
- 52 Week High
- GROY $3.65
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- GROY 65.91
- MRVI 49.60
- Support Level
- GROY $2.89
- MRVI $2.28
- Resistance Level
- GROY $3.37
- MRVI $2.47
- Average True Range (ATR)
- GROY 0.15
- MRVI 0.14
- MACD
- GROY 0.01
- MRVI -0.01
- Stochastic Oscillator
- GROY 85.59
- MRVI 27.45
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.